RATIONALE FOR USE OF DRUGS IN TREATMENT OF DIABETES MELLITUS

被引：0
|
作者：
KRYSTON, LJ [1 ]
SHAW, RA [1 ]
机构：
[1] HAHNEMANN MED COLL & HOSP,PHILADELPHIA,PA 19102
来源：
SEMINARS IN DRUG TREATMENT | 1974年 / 3卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：365 / 375
页数：11
相关论文
共 50 条
  • [41] Anti-obesity drugs in the treatment of type 2 diabetes mellitus
    Quevedo, J.
    Tur, J.
    Serra, G.
    Burguera, B.
    [J]. AVANCES EN DIABETOLOGIA, 2010, 26 (03): : 161 - 166
  • [42] Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
    Sicras-Mainar, Antoni
    Navarro-Artieda, Ruth
    Morano, Raul
    Ruiz, Lucia
    [J]. ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (10): : 527 - 535
  • [43] Risk of Diabetes Treatment Switching or Intensification Associated with Use of Abatacept versus Other Biologic Drugs in Patients with Rheumatoid Arthritis and Diabetes Mellitus
    Chen, Sarah
    Lee, Hemin
    Jin, Yinzhu
    Liu, Jun
    Kim, Seoyoung C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [44] Rationale for the use of drugs in the treatment of cardiovascular disease - 3. Positive inotropes
    Boswood, A
    [J]. IN PRACTICE, 1999, 21 (05) : 253 - +
  • [45] INSULIN PROPHYLAXIS IN INSULIN-DEPENDENT DIABETES-MELLITUS - IMMUNOLOGICAL RATIONALE AND THERAPEUTIC USE
    RAMIYA, V
    MUIR, A
    MACLAREN, N
    [J]. CLINICAL IMMUNOTHERAPEUTICS, 1995, 3 (03): : 177 - 183
  • [46] Rationale for and role of thiazolidinediones in type 2 diabetes mellitus
    Lebovitz, HE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (5A): : 34G - 41G
  • [47] RATIONALE BEHIND THE COMBINATION OF SULFONYLUREA AND METFORMIN IN DIABETES MELLITUS
    Ingle, P. V.
    Talele, G. S.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (07): : 1 - 5
  • [48] Managing Hyperglycemia in Patients With Type 2 Diabetes Mellitus: Rationale for the Use of Dipeptidyl Peptidase-4 Inhibitors in Combination With Other Oral Antidiabetic Drugs
    Freeman, Jeffrey S.
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2010, 110 (09): : 528 - 537
  • [49] RATIONALE FOR INSULIN MANAGEMENT IN GESTATIONAL DIABETES-MELLITUS
    LANGER, O
    BERKUS, M
    BRUSTMAN, L
    ANYAEGBUNAM, A
    MAZZE, R
    [J]. DIABETES, 1991, 40 : 186 - 190
  • [50] Oral hypoglycaemic drugs and newer agents use in TYPE 2 DIABETES MELLITUS
    Joshi, P.
    Joshi, S.
    [J]. SA PHARMACEUTICAL JOURNAL, 2008, 75 (09) : 38 - 43
12345